Lupin announces TB drug partnership, launches key cancer generic in US market

Lupin Limited partners with TB Alliance for Telacebec TB drug and launches Dasatinib Tablets in the US, expanding its specialty and generics portfolio amid evolving pharma strategy.

Leave a Reply

Your email address will not be published. Required fields are marked *